Signify Research July 25, 2019
Alex Green

This morning saw Health Catalyst announce that it expects its common stock to begin trading on the Nasdaq Global Select Market today. This marks the culmination of a journey that started 11 years ago and provides a great illustration of a start-up that has maximised the potential of the move in healthcare to value-based care. However, the IPO comes at a time where there is some uncertainty gripping the markets it targets and there are several key challenges for Health Catalyst to overcome in order to drive future success. Here’s our take on the company’s journey to this point and its future opportunities and challenges as it transitions from start-up to a publicly traded company.

The Journey to IPO


Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: AI (Artificial Intelligence), Analytics, Big Data, Digital Health, Investments, Technology, Trends
Avalyn’s New Twist on Older Lung Disease Drugs Attracts $175M for Clinical Trials
Anthropic Claude 2 : what exactly is this generative AI backed by Amazon with billions of dollars?
Biggest trends and most likely strategic buyers expected to shape Digital Health M&A in 2024
Dollars and Doctors: The Double-Edged Sword of Corporate Healthcare
Midi Health Snags $25M Led by Google Ventures

Share This Article